BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $321,000 | +4.2% | 3,000 | 0.0% | 0.02% | -11.8% |
| Q3 2021 | $308,000 | +16.7% | 3,000 | 0.0% | 0.02% | +21.4% |
| Q2 2021 | $264,000 | -9.6% | 3,000 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $292,000 | -13.1% | 3,000 | 0.0% | 0.02% | -23.8% |
| Q4 2020 | $336,000 | +20.9% | 3,000 | 0.0% | 0.02% | +10.5% |
| Q3 2020 | $278,000 | +18.8% | 3,000 | 0.0% | 0.02% | +11.8% |
| Q2 2020 | $234,000 | -2.5% | 3,000 | 0.0% | 0.02% | +6.2% |
| Q4 2019 | $240,000 | +9.1% | 3,000 | 0.0% | 0.02% | -5.9% |
| Q3 2019 | $220,000 | -22.3% | 3,000 | 0.0% | 0.02% | -19.0% |
| Q2 2019 | $283,000 | +17.9% | 3,000 | 0.0% | 0.02% | +16.7% |
| Q1 2019 | $240,000 | – | 3,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |